Dual action of probiotics is manifested both on the microbiota and the host organism. The interaction of viable probiotic bacteria with other members of intestinal microbiota, achieved by competitive exclusion (competition for nutrients and adhesion sites) and the synthesis of inhibitory molecules is very well documented ([@CIT0001]). The interaction of non-viable probiotics fractions with the host organism is less studied ([@CIT0002]). However, dead probiotic cells could still adhere to specific epithelial cell receptors and stimulate MALT (mucosal lymphoid associated tissue) structures, triggering a local immune response ([@CIT0001]).

Therefore, both live and dead probiotic cells and sub-cellular fractions can generate beneficial biological responses, raising the necessity to elucidate their intimate mechanisms of action and, respectively, the benefits and the potential side effects in each case.

It has been shown that the probiotic cells are producing antimicrobial substances, but also quorum sensing inhibitors (QSIs) which are interfering with the pathogens QS mechanisms and with their virulence genes expression ([@CIT0003]). For example, lactic acid bacteria synthesize bacteriocins depending on the cellular density, using a QS regulatory mechanism, which requires an extracellular accumulation of autoinductor peptides (AI2) that function as chemical messengers ([@CIT0004], [@CIT0005]). There are experimental evidences that the probiotic supernatants (SN), which contain antimicrobial molecules and QS signal molecules, can influence the growth and virulence features expression of some EAggEC (Enteroaggregative *Escherichia coli*) clinical strains ([@CIT0006], [@CIT0007]).

It has been widely demonstrated that probiotics represent a potential effective alternative in the treatment of inflammatory and auto-immune gastrointestinal diseases due to their beneficial effects in modulating the immune response ([@CIT0008]--[@CIT0010]). However, the administration of viable bacterial cells to individuals with weaker immune systems, enhanced inflammatory responses, and/or compromised mucosal barrier functions could turn from 'generally recognized as safe' harmless probiotic bacteria into detrimental ones ([@CIT0011]).

There are also some results showing that gut microbiota and even some bacterial probiotics could be involved in human obesity, for example, when microbiota is enriched in *M. smithii*([@CIT0012], [@CIT0013]) or depleted in this archaeal species; in this last case, some *Bifidobacterium* or *Lactobacillus* species were associated with normal weight (*B. animalis*) while others (*L. reuteri*) were associated with obesity ([@CIT0014]).

Probiotic cell components associated with *in vitro* immunomodulatory properties include entire cell wall ([@CIT0015]) or some components as lypoteichoic acids ([@CIT0016]) and S-layer proteins ([@CIT0017]), or even bacterial DNA ([@CIT0018], [@CIT0019]). Some clinical studies have also suggested that non-viable probiotic fractions can modulate the human immune system, for example, by enhancing secretory IgA production ([@CIT0020]) and by modulating host T-cell responses ([@CIT0021]) and gene expression ([@CIT0022]). In a limited number of *in vitro* and animal studies that have directly compared the effects of viable and inactivated probiotics on innate immunity, these have been found to be equally effective ([@CIT0023]--[@CIT0025]).

There are some evidences that modulation of inflammatory response, as revealed by cytokine profiles, is an important mechanism by which probiotics provide health benefits ([@CIT0026]). For instance, it has been shown that cell surface molecules of *Lactobacillus* sp. strains could elicit strong tumor necrosis factor-alpha (TNF-α) inducing activities in macrophages through Toll-like receptor 2 ([@CIT0016]). In addition, the antimicrobial defensins, cathelicidins, eosinophil-derived neurotoxin, and AI-2 signaling compounds of Gram-positive and Gram-negative bacteria play important roles in intra- and interspecies communication ([@CIT0005], [@CIT0027]).

For some bacterial species, the viability is not necessary to induce cytokine production ([@CIT0028]), the components of dead cells being also able to induce an anti-inflammatory response in the gastrointestinal tract ([@CIT0002]). Dead bifidobacteria induce significant increases in TNF-α production ([@CIT0029]). It was also demonstrated that heat-killed cells of *E. faecalis* stimulate the gastrointestinal immune system in chickens ([@CIT0030]), while administration in healthy dogs increases neutrophil phagocytes number ([@CIT0031]). Based on these observations, it could be stated that probiotic bacteria (as viable cells or non-viable fractions) can act as immunomodulators.

In this context, the objective of this paper was to assess the cytokine serum levels in holoxenic mice after oral administration of non-viable components (NVC) of *Enterococcus faecium* probiotic culture stimulated with heat-inactivated *E. coli* and *Bacillus cereus* in comparison to NVC of unstimulated *E. faecium* culture.

Material and methods {#S0002}
====================

Bacterial strains and growth conditions {#S0002-S20001}
---------------------------------------

Probiotic strain *E. faecium* CMGB16 (isolated from infant faeces) was cultivated in anaerobic conditions, in MRS broth. Enteropathogenic *E. coli* O28 (provided by National Institute of Research and Development for Microbiology and Immunology 'Cantacuzino', Bucharest) and *B. cereus* CMGB 102 (Microbial culture collection of Faculty of Biology, Microbiology Department, University of Bucharest) strains were grown in nutrient broth.

NVC obtaining {#S0002-S20002}
-------------

*E. faecium* CMGB16 was co-cultivated in the presence of heat-inactivated cultures of *E. coli* O28 and *B. cereus*, for 24 hours in MRS broth (Man Rogosa Sharp), in anaerobic conditions, at 37°C. The co-cultivation method was performed by inoculating 4 ml MRS broth with 40 µl of fresh *E. faecium* CMGB16 culture corresponding to standard McFarland 1 (3×10^8^ CFU/ml) and 400 µl of heat-inactivated cultures of *E. coli* O28/*B. cereus* corresponding to standard McFarland 1 (3×10^8^ CFU/ml), before inactivation. The heat-inactivation was performed by autoclaving the bacterial cultures at 121°C for 15 min. After co-cultivation, the NVC components (SNs and cellular fraction) were separated by centrifugation (6,000 rpm, 10 min). The cellular sediment was adjusted to McFarland 1 (3×10^8^ CFU/ml) density in PBS (Phosphate Buffer Saline) and along with integral cultures (IC) was heat-inactivated for 15 min at 121°C. Heat-inactivated cellular suspensions obtained from the cellular sediments (CS), the IC, and the SN were further used for the immunomodulatory activity assay.

Immunomodulatory properties of the obtained NVCs were tested on holoxenic mice (BALB/c mouse strain). Each NVC was orally administered (by using a gradate pipette) in three doses of 0.2 ml/dose to three animals/sample, at 24 hours. Blood samples were collected from the retinal artery, by the non-traumatizing retro-orbital puncture method in the inner corner of the eye. Blood samples were collected after 7, 14, and 21 days from the first administration of the heat-inactivated probiotic fractions.

The serum concentrations of IL-12 and TNF-α interleukins were assessed by ELISA method, using *Mouse ELISA Kit Thermo Scientific* (Pierce Biotechnology, Rockford, UAS), following the manufacturers' instructions. All experiments were performed in triplicates and absorbance was measured on Apollo LB 911 ELISA plate reader set at 450 and 550 nm. A standard curve was generated by plotting the average absorbance obtained for each Standard concentration on the vertical (Y) axis vs. the corresponding IL 12/TNF-α concentration (pg/ml) on the horizontal (X) axis. Using the standard curve, the IL-12/TNF-α amount in each sample was determined by interpolating the absorbance values (Y-axis) to IL-12/TNF-α concentration. In this way, the absorbance results were converted in pg/ml concentrations. These values were plotted on graphs presented in the Results and discussions section. Sensitivity of IL 12 Mouse ELISA kit was \<12 pg/ml and the sensitivity of TNF-α Mouse ELISA kit was \<9 pg/ml.

Results and discussions {#S0003}
=======================

The majority of scientific studies use the term probiotic according to the FAO/WHO (Food and Agriculture Organization of the United Nations/World Health Organization) ([@CIT0032]) definition, i.e. live microorganisms, which when administered in adequate amounts could confer a health benefit on the host. Therefore, this definition requires that the probiotic must be viable, with many studies supporting this idea ([@CIT0033]--[@CIT0036]).

However, there are some scientific findings supporting the positive effects of the probiotic NVCs on health due to the ability of human immune cells to recognize specific bacterial components and metabolic by-products, generating an immunomodulatory effect that involves MALT activation ([@CIT0002]). Chuang ([@CIT0037]) showed that three heat-killed strains of *Lactobacillus* sp. modulated the immune responses by stimulating proliferation of murine splenocytes. In addition, these heat-killed probiotic cells also induced high levels of IL-12 p70 in dendritic cells of mice and the switch to a T helper 1 (Th1) immune response. Given the complexity of the phenomena induced by viable and non-viable probiotics, Taverniti ([@CIT0038]) has proposed the term 'paraprobiotic' defined as non-viable fractions of probiotic origin (inactivated microbial cells or cell fractions), which have been demonstrated to positively affect human/animal health. The study of these paraprobiotics is justified by the opinion of some authors that probiotics could be involved in obesity/metabolic syndrome ([@CIT0039]); simultaneously, the specific effects of probiotic components/culture fractions and targets are important to be known in order to define appropriate clinical applications (similarly to the modern, subunitary vaccines or to immunomodulators). During this study we have used probiotic culture fractions stimulated with other inactivated bacterial cultures, to mimic the interspecies interactions established in the intestinal mucosa. In order to include both probiotic and stimulating bacterial culture components found in the final fractions, we propose the term 'parabiotic', defined as NVC of microbial origin that exhibit beneficial effects on the health of the human or animal host organism.

The serum samples collected after 7, 14, 21 days from the first administration of probiotic fractions were analyzed for IL-12 and TNF-α serum levels by ELISA method. The obtained values represent the average of the determinations performed for each animal batch ([Fig. 1](#F0001){ref-type="fig"}).

![Graphic representation of IL-12 concentration in the serum of holoxenic mice, collected after: I -- 7 days from the first oral administration of NVCs; II -- 14 days from the first oral administration of NVCs; III -- 21 days from the first oral administration of NVCs. IC, integral culture; CS, cellular suspension; SN, supernatant; A, serum collected from holoxenic mice after oral administration of NVC; B, serum collected from holoxenic mice after oral administration of NVC stimulated with *E. coli* O28C; C, serum collected from holoxenic mice after oral administration of NVC stimulated with *B. cereus*; MC, media control -- serum collected from holoxenic mice after oral administration of MRS; NC, negative control -- serum collected from holoxenic mice control.](MEHD-25-23239-g001){#F0001}

The obtained results showed that the age of the animals significantly influenced the serum concentration of IL-12. The highest levels of IL-12 were recorded at 7 days after the first administration of the IC and SN NVCs, especially those stimulated with *B. cereus* ([Fig. 1](#F0001){ref-type="fig"}).

At 14 and 21 days after the first oral administration of probiotic NVCs, the serum concentration of IL-12 generally decreased. In exchange, after the oral administration of SN component stimulated with *B. cereus* and *E. coli*, the serum concentrations of IL-12 were maintained higher in the samples collected after 21 days post-administration. These aspects suggest that *B. cereus* and *E. coli* strains stimulate the synthesis and accumulation in the probiotic cultures SN of bacterial molecules potentially involved in the activation of mucosal intestinal cells, such as macrophages or dendritic cells, to synthesize IL-12. However, it is to be noticed that the unstimulated fractions, particularly CS and SN, also induced high levels of IL-12, especially at 7 and 14 days after the first administration. IL-12 is a cytokine required for the initiation of the immune response, constituting the connecting bridge between non-specific defense reactions (it activates macrophages and NK cells) and specific immune response.

The production of immunomodulatory molecules by probiotic bacteria is thus influenced by the presence of other bacterial species, both Gram-positive and Gram-negative, which inhabit the gut (autochthonous and allochthonous microbiota), by complex and incompletely understood cross-talk mechanisms. The induction of a late immunostimulatory response by these soluble molecules could suggest that they are resistant to digestive enzymes degradation, and could slowly and gradually diffuse in the submucosa, inducing the activation of MALT. This effect was not evident after the administration of CS and IC from the unstimulated NVCs, supporting the hypothesis that the late immunomodulatory effect is due to small, heat-stable, soluble molecules. Studies on peptide fractions (with molecular weight between 2 and 10 Da) isolated from *Lactobacillus helveticus* culture (using HPLC method) showed their immunomodulatory effects after oral administration in holoxenic mice infected with *E. coli* O157:H7 ([@CIT0040]). Cytokine profile of these mice revealed a stimulation of Th2 lymphocyte-mediated response and an increase of the B cells number in the intestine (lamina propria), and thus the concentration of secretory IgA.

The scientific researches states that probiotics (either viable cells or cellular fragments with antigenic potential) must interact with MALT structures (dendritic cells, M cells from the Peyer patches) to generate an immunostimulatory effect, the route of antigen internalization being essential for the initiation of an immune response in the gastrointestinal mucosa ([@CIT0011], [@CIT0028], [@CIT0041]). These observations may explain why the early stimulation of IL-12 synthesis at 7 days after the first administration was induced mainly by the IC stimulated fraction, containing strong particulate antigens.

Being the dominant cytokine involved in the maturation of CD^4+^ T cells, IL-12 plays an important role in immunomodulation, its synthesis being an essential process in triggering early cytokine cascade activation as a response to adjuvants ([@CIT0042]).

In the case of TNF synthesis, the obtained results were variable, no specific cytokine profile dependent on probiotic NVCs, stimulating species, or serum harvesting time being identified. However, at all three harvesting intervals, the highest levels of TNF were induced after the administration of the IC fractions stimulated with *E. coli* ([Fig. 2](#F0002){ref-type="fig"}). After 7 days, the most intensive stimulating effect was obtained for SN fraction stimulated with *B. cereus*, while the un-stimulated CS fraction induced the highest levels of TNF at 14 and 21 days after administration.

![Graphic representation of TNF α concentration in the serum of holoxenic mice, collected after: I -- 7 days from the first oral administration of NVCs; II -- 14 days from the first oral administration of NVCs; III -- 21 days from the first oral administration of NVCs. IC, integral culture, CS, cellular suspension; SN, supernatant; A, serum collected from holoxenic mice after oral administration of NVC; B, serum collected from holoxenic mice after oral administration of NVC stimulated with *E. coli* O28C; C, serum collected from holoxenic mice after oral administration of NVC stimulated with *B. cereus;* MC, media control -- serum collected from holoxenic mice after oral administration of MRS; NC, negative control -- serum collected from holoxenic mice control.](MEHD-25-23239-g002){#F0002}

This effect suggests again that the cellular fragments with strong antigenic properties could induce the activation of macrophage cells from the sub-endothelial compartment (the main TNF producing cells). It has been shown that both crude extracts and purified lipoteichoic acids from *L. casei* and *L. fermentum* could significantly induce TNF secretion by mouse splenic mononuclear cells ([@CIT0016]). This suggests that purified lipoteichoic acids may be a better candidate for clinical use than whole bacteria since they do not contain other bacterial components which might cause side effects ([@CIT0002]).

The induction of TNF-α synthesis by probiotic bacteria, observed in many other studies ([@CIT0028]) seems to be necessary in order to establish functional connections between intestinal epithelial cells and the immune cells (B cells, dendritic cells, macrophages) from the *lamina propria*.

Conclusions {#S0004}
===========

Our results, similar to other scientific studies, demonstrate that inactivated soluble and cellular fractions of probiotic cultures, whose composition can be influenced by the stimulation with other microbial species, could induce immunomodulatory effects mediated by cytokines. Further studies are required in order to identify the chemical nature of these so-called parabiotic fractions.
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